HomeAbout UsContact Us

Cancer Research & Genetics UK

Support|Specific Cancers|Genetics|Research|News|Links

Contact Us

Email us

Charity No.

The charities registered number
is: 1121512

News

Welcome to the latest news page of our website. We shall use this page to let you know any further developments in legislature, medical information or relevant links concerning the genetics of cancer diagnosis and treatment. We shall also be updating you on the funding work carried out by the charity.


1/1/17

Cancer Research Genetics UK have donated £10,000 to Dr Mathew Smalley at Cardiff University and European Cancer Stem Cell Research Institute for new equipment.

The ECSCRI team will purchase equipment for the Marcia Phillips Tissue Culture Suite which will allow them to perform low oxygen cell cultures. Low oxygen levels are often found at the centre of solid tumours, and cancer cells (and normal cells) behave very differently in these conditions. The incubator will allow researchers to mimic these conditions within tumours to determine cancer stem cell behaviour and responses to therapies. In addition they will also purchase a “GentleMACS Disruptor” which allows for automated separation of solid tumour samples into their individual cancer cells without harming the cells in the process.

More research news from Cardiff University.


1/1/17

Cancer Research Genetics UK have donated £10,000 to Professor Ros Eeles Prostate Cancer Genetic Research at the Institute of Cancer Research in London.

ICR logo

Professor Ros Eeles is a leader in prostate cancer genetics at the ICR. She is a scientist as well as a clinician and is looking into new types of testing procedures for early stage prostate cancer.


22/5/16

Cancer Research Genetics UK have donated £10,000 to Professor Ros Eeles Prostate Cancer Genetic Research at the Institute of Cancer Research in London.

Professor Ros Eeles is a leader in prostate cancer genetics at the ICR. She is a scientist as well as a clinician and has discovered 85 of the known 112 common variants associated with prostate cancer predisposition.

She is also is looking into young onset prostate cancer. She has a collection UK-wide of 10,000 young onset prostate cancer case samples (diagnosed at 60 years or less). She is looking to identify genetic alterations which are particularly found in young onset disease to enable ICR to use these in targeted screening and treatment trials.

To learn more visit the IRC Facebook page - click here.


1/12/15

Cancer Research Genetics UK have donated £10,000 to Prof Alan Clark's cancer stem cell research at Cardiff University.

To see more information on Prof Clark's work - click here.


Professor Clarke's main interest is in the molecular basis of cancer, particularly in the very early stages when cells initially diverge from normality.

Professor Clarke's group will work with the Research Institute on the genetic origins of cancer stem cells, and the susceptibility of these cells to existing and new therapies.


20/11/15

Cancer Research Genetics UK have donated £10,000 to Dr Marco Gerlinger’s research. His work involves developing novel strategies to overcome drug resistance in advanced Bowel cancer. He is based at the Institute of Cancer Research London which is linked to the Royal Marsden Hospital.

To see more information on Dr Gerlinger's work - click here.

He is developing novel strategies to overcome drug resistance in advanced bowel cancer.


24/03/15

ICR logo

Cancer Research and Genetics UK have just donated £10,000 to The Institute of Cancer Research (ICR) to help with Professor Richard Houlston's work in cancer genetics.

The ICR is in London and it has working links for cancer genetic research with the Royal Marsden Hospital, London.

The ICR has some of the world’s leading scientists identifying the genes that predispose us to cancer.

www.icr.ac.uk

To read more about the centre's work click here.


17/11/14


We have donated £10,000 to the work of Professor Philip Rudland at Liverpool University who is looking at the identification of genetic changes that promote the spread of cancer in the body.

Aim of Project
We need to know why these metastasis-inducing genes are preferentially turned on in some patients contributing to their early death, but not in others enabling them to survive much longer.

To read the full application please click here.

The University of Liverpool would like to thank Cancer Research Genetics UK for supporting their work on cancer research.


5/11/14

 

 

 


Cancer Research Genetic's have made a donation of £10,000 to the work of Professor Alan Clark and the European Cancer Stem Cell Research Institute, based at Cardiff University.

Professor Clark feels that this money would bring significant benefit to ECSCRI and the research that is undertaken therein. At the moment the Institute is looking to purchase the following hi-tec equipment:


28/7/2011

Cancer Research and Genetics UK are currently regularly donating to Professor Alan Clarke and his European Cancer Stem Cell Research Institute (ECSCRI) based at Cardiff University.


14/5/2011

Doctors (GPs) miss one in three cancer cases - click here.

30/4/2011

Cancer Research and Genetics UK are currently donating regularly to Professor Julian Sampson's Cancer Genetic Research work at Cardiff University.

1/1/2011

Cancer Research and Genetics UK are working in collaboration with Recycle Proline LTD a company based in Liverpool who are donating funds regularly to the charity which is directed into Cancer Research and Genetics and to the charities objectives and aims.


Total Health

Genetic link to childhood cancer - click here.

ICR news

Bowel cancer gene found - click here.

NICE news

Thoracoscopic excision of mediastinal parathyroid tumours - click here.

ECPC news

ECPC logo

We have exciting news from the European Parliament. The Committee on Environment/Public Health has tabled a draft Resolution on “Combating cancer in the enlarged European Union”. The draft Resolution and Oral question is now posted on the European Parliament website, eventually in all official EU languages. The Resolution is expected to be adopted by the European Parliament plenary in the week of 18 February or 10 March 2008. In our view this will make an excellent contribution to the Slovenian Presidency cancer agenda. Please note that the Resolution once adopted will be forwarded to your national parliament. We hope this provides you with opportunities to make the case for improved cancer control in your country.

Oral question -  click here.

Draft Motion for Resolution - click here.

Home|Support|Specific Cancers|Genetics|Research|News|Links|Contact Us